KV Pharmaceutical

#	Item
1	USCA Case #[removed]Document #[removed]Filed: [removed] Add to Reading List Source URL: www.hpm.com Language: English - Date: 2014-12-17 12:04:58 Health Food and Drug Administration Clinical pharmacology Therapeutics United States Public Health Service KV Pharmaceutical 17-Hydroxyprogesterone caproate Compounding FDA Warning Letter Pharmacology Pharmaceutical sciences Clinical research
2	Makena (hydroxyprogesterone caproate) injection label Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2013-09-17 09:06:14 Medicine 17-Hydroxyprogesterone caproate 17-Hydroxyprogesterone KV Pharmaceutical Progestin Progesterone Preterm birth Pregnancy Pre-eclampsia Endocrine system Progestagens Steroid hormones
3	Consent Decree of Permanent Injunction: KV Pharmaceutical Add to Reading List Source URL: www.fda.gov Language: English Medicine Health Drug safety Pharmaceuticals policy Food safety Good manufacturing practice New Drug Application Investigational New Drug Pharmaceutical industry Pharmaceutical sciences Food and Drug Administration